Fig. 1: SARS-CoV-2 variants analysed in this study.
From: Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic
a, Map highlighting the country where the first sequence of the variants assessed in this study was reported on GISAID. b, Global quarterly sequence count for each variant, scaled independently to highlight the peak occurrence of each SARS-CoV-2 variant. Red scaling is used for variants with >100,000 sequences, while orange and yellow are used for those with more or less than 1,000 sequences, respectively. c, Schematic representation of the spike recombinant viruses used in this study. 10* refers to Orf10 as a putative accessory protein, as there is ongoing debate in the literature regarding its existence and expression.
